RYBURN PHARMACY (RIPPONDEN) LIMITED Financials
- Company number
- 04952659CopyCopy
- Registered office
- First Floor, Rosemount House, Huddersfield Road, Elland, West Yorkshire HX5 0EE
- Incorporated
- 04/11/2003
Company snapshot
- Status
- Active
- Employees
- 12 (2026)
- Latest financial data
- 2026
- Accounts type
- Total Exemption Full
Financial highlights
Latest reported figures. Okredo holds filed data for 2022–2026.
Net Assets
3.53%vs 20252025: £570.33K
Total Assets
4.09%vs 20252025: £934.71K
Cash in Bank
4.48%vs 20252025: £697.73K
Total Liabilities
4.98%vs 20252025: £364.38K
Employees
0vs 20252025: 12
In 2026, RYBURN PHARMACY (RIPPONDEN) LIMITED reported net assets of £590.45K. The same filing shows total assets of £972.99K, cash in bank of £729.02K and total liabilities of £382.53K. Reported headcount was 12 in 2026. Total Assets rose from £934.71K in 2025 to £972.99K in 2026 (4.09%). Okredo holds filed figures for 2022–2026; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
3.53%from £570.33K in 2025Year-on-year change
Net Assets as filed for 2022–2026. Every figure in this chart is also in the financial history table.
3-year financial trend (2024–2026)
How the figures RYBURN PHARMACY (RIPPONDEN) LIMITED filed moved across the three reported years 2024, 2025 and 2026 — measured end to end rather than year on year.
Net Assets
-0.9%vs 2024-0.5% a year compound (CAGR)
Cash in Bank
+8.2%vs 2024+4% a year compound (CAGR)
Total Assets
+5.8%vs 2024+2.8% a year compound (CAGR)
Total Liabilities
+18%vs 2024+8.6% a year compound (CAGR)
Employees
+9.1%vs 2024+1Biggest increase
Total Liabilities+18%
£324.09K in 2024 to £382.53K in 2026
Biggest decrease
Net Assets-0.9%
£595.95K in 2024 to £590.45K in 2026
RYBURN PHARMACY (RIPPONDEN) LIMITED's filings pull in both directions between 2024 and 2026. The steepest rise came in total liabilities, pointing to heavier outstanding obligations, set against a fall in net assets, pointing to a weakening balance sheet. See the full year-by-year figures.
Ratios from the filed figures
Calculated from RYBURN PHARMACY (RIPPONDEN) LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 60.68%2026
- Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
- Liabilities to total assets
- 39.32%2026
- Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
- Cash to liabilities
- 190.58%2026
- Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
- Cash to total assets
- 74.93%2026
- Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for RYBURN PHARMACY (RIPPONDEN) LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Assets£ | 615.02K | 596.25K | 595.95K | 570.33K | 590.45K |
| Total Assets£ | 934.04K | 909.85K | 920.04K | 934.71K | 972.99K |
| Cash in Bank£ | 599.07K | 671.08K | 673.48K | 697.73K | 729.02K |
| Total Liabilities£ | 319.02K | 313.60K | 324.09K | 364.38K | 382.53K |
| Employees | 11 | 12 | 11 | 12 | 12 |
RYBURN PHARMACY (RIPPONDEN) LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Yes. Okredo holds filed figures for RYBURN PHARMACY (RIPPONDEN) LIMITED covering 2022–2026, across 5 reported indicators. The most recent reported year is 2026.
RYBURN PHARMACY (RIPPONDEN) LIMITED reported net assets of £590.45K for 2026. That compares with £570.33K in 2025, a change of 3.53%.
RYBURN PHARMACY (RIPPONDEN) LIMITED reported total assets of £972.99K for 2026. That compares with £934.71K in 2025, a change of 4.09%.
RYBURN PHARMACY (RIPPONDEN) LIMITED reported cash in bank of £729.02K for 2026. That compares with £697.73K in 2025, a change of 4.48%.
RYBURN PHARMACY (RIPPONDEN) LIMITED reported 12 employees in 2026, compared with 12 in 2025.
Between 2024 and 2026, RYBURN PHARMACY (RIPPONDEN) LIMITED's net assets fell by 0.9%, cash in bank rose by 8.2%, total assets rose by 5.8% and total liabilities rose by 18%. Net assets contracted at 0.5% a year across the two years to 2026, from £595.95K to £590.45K. Reported headcount went from 11 in 2024 to 12 in 2026 (+1).
Okredo holds reported figures for the years 2022, 2023, 2024, 2025, 2026. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.